Page last updated: 2024-09-05
vx-745 and Stroke
vx-745 has been researched along with Stroke in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Alam, JJ; Germann, U; Krakovsky, M; Levy, A | 1 |
Other Studies
1 other study(ies) available for vx-745 and Stroke
| Article | Year |
|---|---|
Continuous administration of a p38α inhibitor during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied by increase in brain BDNF protein level.
Topics: Animals; Brain; Brain Ischemia; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Ischemia; Male; Mitogen-Activated Protein Kinase 14; p38 Mitogen-Activated Protein Kinases; Pyridazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Recovery of Function; Stroke | 2020 |